Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RXRX | Class A Common Stock | Sale | -$305K | -14.9K | -1.12% | $20.44 | 1.32M | Dec 7, 2021 | By Dean Y. Li 2021 GRAT | F1, F2 |
transaction | RXRX | Class A Common Stock | Sale | -$21.1K | -1K | -0.08% | $21.06 | 1.32M | Dec 7, 2021 | By Dean Y. Li 2021 GRAT | F1, F3 |
holding | RXRX | Class A Common Stock | 1.42M | Dec 7, 2021 | By Dean Li and Ruth Li Revocable Trust | ||||||
holding | RXRX | Class A Common Stock | 450K | Dec 7, 2021 | By Dean Y. Li 2021 Family Trust | ||||||
holding | RXRX | Class A Common Stock | 597K | Dec 7, 2021 | Direct |
Id | Content |
---|---|
F1 | Sales are pursuant to a 10b5-1 trading plan established by the Reporting Person. |
F2 | The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.01 to $20.995 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
F3 | The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $21.03 to $21.11 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |